Logo image of NNE

NANO NUCLEAR ENERGY INC (NNE) Stock Fundamental Analysis

NASDAQ:NNE - Nasdaq - US63010H1086 - Common Stock - Currency: USD

35.86  -1.21 (-3.26%)

Fundamental Rating

2

NNE gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 93 industry peers in the Electrical Equipment industry. No worries on liquidiy or solvency for NNE as it has an excellent financial health rating, but there are worries on the profitability. NNE has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

NNE had negative earnings in the past year.
NNE had a negative operating cash flow in the past year.
NNE Yearly Net Income VS EBIT VS OCF VS FCFNNE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

With a Return On Assets value of -114.45%, NNE is not doing good in the industry: 85.87% of the companies in the same industry are doing better.
NNE has a Return On Equity of -152.98%. This is in the lower half of the industry: NNE underperforms 70.65% of its industry peers.
Industry RankSector Rank
ROA -114.45%
ROE -152.98%
ROIC N/A
ROA(3y)-53.75%
ROA(5y)N/A
ROE(3y)-56.74%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NNE Yearly ROA, ROE, ROICNNE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for NNE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NNE Yearly Profit, Operating, Gross MarginsNNE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024

8

2. Health

2.1 Basic Checks

NNE has more shares outstanding than it did 1 year ago.
There is no outstanding debt for NNE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
NNE Yearly Shares OutstandingNNE Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 10M 20M 30M
NNE Yearly Total Debt VS Total AssetsNNE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 10M 20M 30M

2.2 Solvency

An Altman-Z score of 327.01 indicates that NNE is not in any danger for bankruptcy at the moment.
NNE has a Altman-Z score of 327.01. This is amongst the best in the industry. NNE outperforms 100.00% of its industry peers.
NNE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 327.01
ROIC/WACCN/A
WACCN/A
NNE Yearly LT Debt VS Equity VS FCFNNE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 10M -10M 20M 30M

2.3 Liquidity

NNE has a Current Ratio of 10.88. This indicates that NNE is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 10.88, NNE belongs to the best of the industry, outperforming 95.65% of the companies in the same industry.
A Quick Ratio of 10.88 indicates that NNE has no problem at all paying its short term obligations.
The Quick ratio of NNE (10.88) is better than 96.74% of its industry peers.
Industry RankSector Rank
Current Ratio 10.88
Quick Ratio 10.88
NNE Yearly Current Assets VS Current LiabilitesNNE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 5M 10M 15M 20M 25M

0

3. Growth

3.1 Past

NNE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -76.95%.
EPS 1Y (TTM)-76.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-75.49%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

NNE is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -34.68% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-118.18%
EPS Next 2Y-32.29%
EPS Next 3Y-34.68%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NNE Yearly Revenue VS EstimatesNNE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 10M 20M 30M
NNE Yearly EPS VS EstimatesNNE Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 -0.2 -0.4 -0.6 -0.8 -1

0

4. Valuation

4.1 Price/Earnings Ratio

NNE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NNE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NNE Price Earnings VS Forward Price EarningsNNE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NNE Per share dataNNE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8

4.3 Compensation for Growth

A cheap valuation may be justified as NNE's earnings are expected to decrease with -34.68% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-32.29%
EPS Next 3Y-34.68%

0

5. Dividend

5.1 Amount

NNE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NANO NUCLEAR ENERGY INC

NASDAQ:NNE (2/5/2025, 2:41:08 PM)

35.86

-1.21 (-3.26%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)12-30 2024-12-30/bmo
Earnings (Next)N/A N/A
Inst Owners0.82%
Inst Owner Change47.83%
Ins Owners9.84%
Ins Owner Change0%
Market Cap1.19B
Analysts80
Price Target48.45 (35.11%)
Short Float %20.72%
Short Ratio0.73
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-18.1%
PT rev (3m)21.79%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)15.04%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-18.97%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 180.06
P/tB 180.06
EV/EBITDA N/A
EPS(TTM)-0.37
EYN/A
EPS(NY)-0.97
Fwd EYN/A
FCF(TTM)-0.31
FCFYN/A
OCF(TTM)-0.25
OCFYN/A
SpS0
BVpS0.2
TBVpS0.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -114.45%
ROE -152.98%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-53.75%
ROA(5y)N/A
ROE(3y)-56.74%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 16361.9%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.88
Quick Ratio 10.88
Altman-Z 327.01
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-76.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-75.49%
EPS Next Y-118.18%
EPS Next 2Y-32.29%
EPS Next 3Y-34.68%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-67.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-49.97%
EBIT Next 3Y-38.95%
EBIT Next 5YN/A
FCF growth 1Y-162.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-118.85%
OCF growth 3YN/A
OCF growth 5YN/A